Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.14 USD | +2.53% | -0.65% | -47.47% |
08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.47% | 62Cr | |
+34.35% | 69TCr | |
+29.39% | 58TCr | |
-3.49% | 37TCr | |
+20.15% | 33TCr | |
+6.19% | 29TCr | |
+14.11% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+9.21% | 17TCr |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024